Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:523-527
Published online before print September 29, 2003, doi: 10.1161/01.HYP.0000093383.18302.A7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/523    most recent
01.HYP.0000093383.18302.A7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rong, P.
Right arrow Articles by Skinner, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rong, P.
Right arrow Articles by Skinner, S. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Animal models of human disease
Right arrow Energy metabolism

(Hypertension. 2003;42:523.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Hypertension in the (mRen-2)27 Rat Is Not Explained by Enhanced Kinetics of Transgenic Ren-2 Renin

Pei Rong; Duncan J. Campbell; Sandford L. Skinner

From the Department of Physiology (P.R., S.L.S.) and St Vincent’s Institute of Medical Research and Department of Medicine (D.J.C), University of Melbourne, Melbourne, Australia.

Correspondence to Sandford L. Skinner, MD, Department of Physiology, University of Melbourne, Victoria 3010, Australia. E-mail s.skinner{at}physiology.unimelb.edu.au

Enhanced efficiency of the reaction between transgenic Ren-2 mouse renin and endogenous rat angiotensinogen has been suggested as 1 mechanism that contributes to the accelerated hypertension and increased tissue angiotensin of the (mRen-2)27 transgenic rat. This was tested in a study conducted at pH 7.4 in vitro that compared the kinetic constants of purified mouse Ren-2 and rat renin (each at 100, 75, 50, and 25 pmol/L) reacting with physiologic concentrations of rat angiotensinogen (0 to 4 µmol/L). Under these conditions, the kinetic constants for Ren-2 (Km, 1.8 µmol/L; Kcat, 0.07/s; and Kcat/Km, 0.04 L · µmol-1 · s-1) were not different from rat renin. However, Ren-2 renin acting on its homologous mouse angiotensinogen was confirmed as being much slower. We conclude that hypertension in the Ren-2 rat is not related to renin kinetics. Other mechanisms are considered, with reference to human essential hypertension.


Key Words: renin-angiotensin system • angiotensinogen • blood pressure • hypertension, essential




This article has been cited by other articles:


Home page
HypertensionHome page
D. J. Campbell, H. Karam, J. Menard, P. Bruneval, and J. J. Mullins
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver
Hypertension, December 1, 2009; 54(6): 1248 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]